Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial Carcinoma

被引：0
作者：
Drake, Marcus J. [1 ]
Birder, Lori A. [2 ]
机构：
[1] Imperial Coll London, Dept Surg & Canc, London, England
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
来源：
EUROPEAN UROLOGY | 2024年 / 86卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2024.03.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 5 条
  • [1] Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER)
    Abrams, Paul
    Constable, Lynda D.
    Cooper, David
    MacLennan, Graeme
    Drake, Marcus J.
    Harding, Chris
    Mundy, Anthony
    McCormack, Kirsty
    McDonald, Alison
    Norrie, John
    Ramsay, Craig
    Smith, Rebecca
    Cotterill, Nikki
    Kilonzo, Mary
    Glazener, Cathryn
    [J]. EUROPEAN UROLOGY, 2021, 79 (06) : 812 - 823
  • [2] Neural Control of the Lower Urinary Tract: Peripheral and Spinal Mechanisms
    Birder, L.
    de Groat, W.
    Mills, I.
    Morrison, J.
    Thor, K.
    Drake, M.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2010, 29 (01) : 128 - 139
  • [3] Factors Influencing Lower Urinary Tract Symptoms in Advanced Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy
    Cho, Ok-Hee
    Yoo, Yang-Sook
    Kim, Joon Chul
    Park, Ran Hee
    Hwang, Kyung-Hye
    [J]. INTERNATIONAL NEUROUROLOGY JOURNAL, 2018, 22 (03) : 192 - 199
  • [4] Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
    Powles, Thomas
    Rosenberg, Jonathan E.
    Sonpavde, Guru P.
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Castellano, Daniel
    Wu, Chunzhang
    Campbell, Mary
    Matsangou, Maria
    Petrylak, Daniel P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12) : 1125 - 1135
  • [5] EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
    Rosenberg, J. E.
    Powles, T.
    Sonpavde, G. P.
    Loriot, Y.
    Duran, I.
    Lee, J. -L.
    Matsubara, N.
    Vulsteke, C.
    Castellano, D.
    Mamtani, R.
    Wu, C.
    Matsangou, M.
    Campbell, M.
    Petrylak, D. P.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 (11) : 1047 - 1054
1